Zoology Department, Faculty of Science, Fayoum University, Fayoum, Egypt.
Physiology Department, National Organization of Drug Control and Research (NODCAR), Giza, Egypt.
Acta Parasitol. 2022 Jun;67(2):773-783. doi: 10.1007/s11686-021-00513-1. Epub 2022 Jan 24.
Although praziquantel (PZQ) has a wide use as an anti-schistosome agent, many of its imperfections and side effects have been reported in many studies. The current study aims to evaluate the curative effect of a natural dandelion extract (Taraxacum officinale) on schistosomiasis either alone or in combination with PZQ based on parasitological, immunological, histopathological and molecular investigations.
Mice were experimentally infected with Schistosoma mansoni cercariae and then divided into four groups, Schistosoma spp.-infected untreated group (IC group), Schistosoma spp.-infected group of mice treated with dandelion (I-Dn group), Schistosoma spp.-infected group of mice treated with PZQ (I-PZQ group), and Schistosoma spp.-infected group of mice treated with both PZQ and dandelion (I-PZQ + Dn group). Treatment started 45 days' post-infection. Besides, non-infected, non-treated mice served as the negative healthy control group (HC group).
The present results indicated that dandelion administration significantly reduced the worm burden, ova number, and the number and diameter of hepatic granulomas as compared to the untreated infected group. The results also showed that the levels of IL-6 and TNF-α were significantly decreased in the combined treatment group (I-PZQ + Dn) as compared to the I-PZQ group. Administration of dandelion-only remarkably reduced AST and ALT activities associated with schistosomiasis. Moreover, hepatic DNA damage assessed by comet assay was significantly inhibited in the combined treated group compared to the infected untreated and PZQ treated groups.
The results concluded that combined treatment of PZQ and dandelion extract improved immune response, decreased the number and diameter of granulomas, and inhibited DNA damage, indicating a reduction in liver fibrosis associated with schistosomiasis. The present study focused on the potential effect of dandelion as an adjunct medication for therapeutic properties of PZQ.
尽管吡喹酮(PZQ)作为一种抗血吸虫药物被广泛应用,但许多研究已经报道了它的许多缺陷和副作用。本研究旨在评估蒲公英提取物(Taraxacum officinale)单独或与 PZQ 联合治疗血吸虫病的疗效,通过寄生虫学、免疫学、组织病理学和分子研究进行评估。
将小鼠用曼氏血吸虫尾蚴感染进行实验感染,然后将其分为四组,未治疗的曼氏血吸虫感染组(IC 组)、用蒲公英治疗的曼氏血吸虫感染组(I-Dn 组)、用 PZQ 治疗的曼氏血吸虫感染组(I-PZQ 组)和用 PZQ 和蒲公英联合治疗的曼氏血吸虫感染组(I-PZQ+Dn 组)。治疗于感染后 45 天开始。此外,未感染、未治疗的小鼠作为阴性健康对照组(HC 组)。
本研究结果表明,与未治疗的感染组相比,蒲公英给药显著降低了虫体负荷、卵数以及肝肉芽肿的数量和直径。结果还表明,与 I-PZQ 组相比,联合治疗组(I-PZQ+Dn)的 IL-6 和 TNF-α 水平显著降低。蒲公英单独给药还显著降低了与血吸虫病相关的 AST 和 ALT 活性。此外,与未感染和 PZQ 治疗组相比,联合治疗组的彗星试验评估的肝 DNA 损伤明显受到抑制。
研究结果表明,PZQ 和蒲公英提取物联合治疗改善了免疫反应,减少了肉芽肿的数量和直径,并抑制了 DNA 损伤,表明与血吸虫病相关的肝纤维化减少。本研究重点研究了蒲公英作为 PZQ 治疗特性的辅助药物的潜在作用。